These data indicate that TIM‐4 activation in KCs is involved in the pathogenesis of CCL4‐injured liver fibrosis, and TIM‐4 interference contributes to liver fibrosis resolution. The gene discussed is TIMD4; the disease is Hepatic fibrosis.